Utah Medical Products (NASDAQ:UTMD) Stock Crosses Below 200 Day Moving Average – Here’s What Happened

Utah Medical Products, Inc. (NASDAQ:UTMD)’s share price passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $58.26 and traded as low as $57.12. Utah Medical Products shares last traded at $57.39, with a volume of 10,823 shares trading hands.

Analysts Set New Price Targets

Separately, Weiss Ratings reissued a “sell (d+)” rating on shares of Utah Medical Products in a research note on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock has a consensus rating of “Sell”.

Utah Medical Products Stock Performance

The company’s 50 day moving average price is $57.39 and its 200 day moving average price is $58.26. The company has a market cap of $183.88 million, a price-to-earnings ratio of 16.21 and a beta of 0.33.

Utah Medical Products (NASDAQ:UTMD) last released its quarterly earnings data on Thursday, October 23rd. The medical instruments supplier reported $0.82 earnings per share (EPS) for the quarter. The business had revenue of $9.81 million during the quarter. Utah Medical Products had a net margin of 30.08% and a return on equity of 9.89%.

Utah Medical Products Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, January 5th. Stockholders of record on Tuesday, December 16th will be paid a dividend of $0.31 per share. This is a boost from Utah Medical Products’s previous quarterly dividend of $0.31. The ex-dividend date is Tuesday, December 16th. This represents a $1.24 annualized dividend and a dividend yield of 2.2%. Utah Medical Products’s dividend payout ratio is currently 35.03%.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the stock. Nuveen LLC bought a new position in shares of Utah Medical Products in the first quarter valued at approximately $449,000. Jump Financial LLC bought a new stake in shares of Utah Medical Products during the 1st quarter worth $370,000. Brandes Investment Partners LP boosted its holdings in shares of Utah Medical Products by 12.0% during the 2nd quarter. Brandes Investment Partners LP now owns 271,322 shares of the medical instruments supplier’s stock worth $15,444,000 after buying an additional 29,073 shares during the period. Hotchkis & Wiley Capital Management LLC grew its stake in Utah Medical Products by 35.2% in the 1st quarter. Hotchkis & Wiley Capital Management LLC now owns 101,640 shares of the medical instruments supplier’s stock valued at $5,696,000 after buying an additional 26,460 shares during the last quarter. Finally, LSV Asset Management raised its holdings in Utah Medical Products by 8.8% in the 2nd quarter. LSV Asset Management now owns 12,974 shares of the medical instruments supplier’s stock worth $738,000 after acquiring an additional 1,053 shares during the period. 69.60% of the stock is owned by institutional investors.

About Utah Medical Products

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.